Timing could be better, but, there are some positives...While recognizing we are undervalued, the timing of the review isn't optimal. It's like putting your house on the market during rising interest rates (like now). On the other hand, a potential buyout will make short sellers think twice. So overall, it's a positive IMO. The only real risk is time it takes to come up with something, and Q4 earnings. The longer the process drags out could become an issue if Q4 earnings surprise to the downside. So all in all, we'll be rangebound IMO, which is A OK with me. Stabilizing the price around $5 is a good thing. A lot better than what we've been experiencing as of late.